Growth Outcomes in Individuals with Idiopathic Short Stature Treated with Growth Hormone Therapy

2011 ◽  
Vol 76 (s3) ◽  
pp. 42-45 ◽  
Author(s):  
Jovanna Dahlgren
Keyword(s):  
Growth Hormone ◽  
Hormone Therapy ◽  
Short Stature ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature ◽  
Growth Outcomes

Growth hormone therapy in children with idiopathic short stature – the effect on appetite and appetite-regulating hormones: a pilot study

2018 ◽  
Vol 44 (1-2) ◽  
pp. 16-26 ◽  
Author(s):  
Michal Yackobovitch-Gavan ◽  
Galia Gat-Yablonski ◽  
Biana Shtaif ◽  
Shir Hadani ◽  
Shiran Abargil ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Pilot Study ◽  
Hormone Therapy ◽  
Short Stature ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature

Age at Growth Hormone Therapy Start and First-Year Responsiveness to Growth Hormone Are Major Determinants of Height Outcome in Idiopathic Short Stature

2007 ◽  
Vol 68 (2) ◽  
pp. 53-62 ◽  
Author(s):  
Michael B. Ranke ◽  
Anders Lindberg ◽  
David A. Price ◽  
Feyza Darendeliler ◽  
Kerstin Albertsson-Wikland ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Hormone Therapy ◽  
Short Stature ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature ◽  
First Year

scholarly journals The Efficiency of Recombined Growth Hormone Therapy in Idiopathic Short Stature

2019 ◽  
Vol 70 (2) ◽  
pp. 571-574
Author(s):  
Alin Demetrian ◽  
Smaranda Adelina Preda ◽  
Oana Mariana Cristea ◽  
Carmen Dragomirescu ◽  
Ionela Mihaela Vladu
Keyword(s):  
Growth Hormone ◽  
Hormone Therapy ◽  
Short Stature ◽  
Chromosomal Abnormalities ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature ◽  
Public Health Issue ◽  
Major Public Health Issue ◽  
Normal Stature ◽  
Height For Age

Idiopathic short stature (ISS) deficiency reflects a major public health issue. In Romania the incidence is 1/3000 - 6000 births, with an increased prevalence in boys. ISS is the condition where the height of a subject is more than -2.5 DS below the height of the population for the population in which it is included, below the mean height for age and sex, but without any nutritional, systemic or chromosomal abnormalities. Significant for children with ISS is that weight is normal at birth and growth hormone levels are normal. This study shows the evolution of the height to normal values specific to the biological age, reaching the normal stature, according to auxological parameters, after growth hormone therapy.

scholarly journals Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy

2011 ◽  
Vol 17 (3) ◽  
pp. 218 ◽  
Author(s):  
NagwaAbdallah Ismail ◽  
FatmaAhmed El-Moguy ◽  
SohaM Abd El Dayem ◽  
NermeenSalah Eldin Metwaly ◽  
MonaHassan Hafez ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Hormone Therapy ◽  
Short Stature ◽  
Growth Response ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature ◽  
Egyptian Children

Growth hormone therapy with three dosage regimens in children with idiopathic short stature

1998 ◽  
Vol 132 (3) ◽  
pp. 455-460 ◽  
Author(s):  
L.T.M. Rekers-Mombarg ◽  
G.G. Massa ◽  
J.M. Wit ◽  
A.M.C. Matranga ◽  
J.M.H. Buckler ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Hormone Therapy ◽  
Short Stature ◽  
Growth Hormone Therapy ◽  
Idiopathic Short Stature ◽  
Dosage Regimens
Sign in / Sign up

Export Citation Format

Share Document